Review article

Chronic kidney disease and atrial fibrillation.

Bruna Sanader ; University Hospital Centre Sestre milosrdnice, Zagreb, Croatia
Lana Pintarić ; University Hospital Centre Sestre milosrdnice, Zagreb, Croatia
Josipa Josipović ; University Hospital Centre Sestre milosrdnice, Zagreb, Croatia
Draško Pavlović orcid.org/0000-0002-2380-869X ; University Hospital Centre Sestre milosrdnice, Zagreb, Croatia

Abstract

Chronic kidney disease (CKD) is defined by structural or functional kidney abnormalities for more than three months with a significant impact on health. The major causes of CKD are diabetes and arterial hypertension. Therefore, the increasing incidence of this disease in almost all parts of the world is not surprising. Patients with CKD are more likely to develop cardiovascular diseases (CVD) than the rest of the population, and we know that they are the major cause of death in dialysis patients. Atrial fibrillation (AF), as the most common cardiac arrhythmia, has a higher prevalence among the patients with impaired renal function, therefore it is an extremely important health issue. On the other hand, patients with progressing CKD and who present a diagnosis of AF show a significantly higher risk of death. There are no clear guidelines for the treatment of AF in patients with CKD. The administration of warfarin to prevent stokes, a frequent complication of cardiac arrhythmia, is particularly debatable. Further trials of CKD and CVD are to be conducted and should include the close collaboration of nephrologists and cardiologists.

Keywords

chronic kidney disease; cardiovascular diseases; atrial fibrillation

Hrčak ID:

146874

URI

https://hrcak.srce.hr/146874

Publication date:

26.3.2014.

Article data in other languages: croatian

Visits: 1.374 *